logo
Book a meeting
CartiHeal

Carti Heal

Medical Devices, 3 Reuten Dr, Kfar Saba, New Jersey, 07624, United States, 51-200 Employees

cartiheal.com

  • facebook
  • LinkedIn

Who is CARTIHEAL

CartiHeal, a privately-held medical device company with headquarters in Israel, develops proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and ost...

Read More

lock icon Get Full Access
map
  • 3 Reuten Dr, Kfar Saba, New Jersey, 07624, United States Headquarters: 3 Reuten Dr, Kfar Saba, New Jersey, 07624, United States
  • 2009 Date Founded: 2009
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 3827

checked-icon Does something look wrong? Fix it. | View contact records from CARTIHEAL

CartiHeal Org Chart and Mapping

Employees
Adam Waksman

Adam Waksman

Director of Clinical Affairs

See Full Org Chart arrow
email-formate-icon
View Email Formats for CartiHeal
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding CartiHeal

Answer: CartiHeal's headquarters are located at 3 Reuten Dr, Kfar Saba, New Jersey, 07624, United States

Answer: CartiHeal's official website is https://cartiheal.com

Answer: CartiHeal's revenue is $1 Million to $5 Million

Answer: CartiHeal's SIC: 3827

Answer: CartiHeal has 51-200 employees

Answer: CartiHeal is in Medical Devices

Answer: CartiHeal contact info: Phone number: Website: https://cartiheal.com

Answer: CartiHeal, a privately-held medical device company with headquarters in Israel, develops proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints. CartiHeals cell-free, off-the-shelf implant is CE marked for use in cartilage and osteochondral defects. Agili-C has been implanted in over 400 patients with cartilage lesions in the knee, ankle and great toe in a series of trials conducted in leading centers in Europe and Israel. In these trials, the implant was used to treat a broad spectrum of cartilage lesions, from single focal lesions to multiple and large defects in patients suffering from osteoarthritis. In the United States the Agili-C implant is not available for sale - it is an investigational device limited for use in the IDE study.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access